and yes we do celebrate
This is all about their clinical trials and that they are ahead of the competition.
Now there's a 1st.(post that is)
Been with board for some time. We could expect even better and after hour action as well. I think we do have an easy triple here and if shorts do not like it go away
I agree. I sold my ARIA to buy CRIS after some due diligence.Roche is a serial acquirer of promising companies. This would be a morale booster for Genentech if Roche said to its scientists, "here's a gift from the home office in Switzerland; run with it."
You guys are ridiculous. New ID's and all of a sudden you're the biggest fans. Please go away. Oh yeah, you will be after today.LOL
$3 by close?
Definately worth more than $3. I would not want to be short over the weekend.